Zhu, L.; Han, Y.; Lu, J.; Tan, J.; Liao, C.; Guo, C.; He, Q.; Qiu, Y.; Lu, H.; Zhou, Y.;
et al. Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case–Control Study. Vaccines 2025, 13, 4.
https://doi.org/10.3390/vaccines13010004
AMA Style
Zhu L, Han Y, Lu J, Tan J, Liao C, Guo C, He Q, Qiu Y, Lu H, Zhou Y,
et al. Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case–Control Study. Vaccines. 2025; 13(1):4.
https://doi.org/10.3390/vaccines13010004
Chicago/Turabian Style
Zhu, Liyan, Ying Han, Jiahai Lu, Jianhao Tan, Conghui Liao, Cheng Guo, Qing He, Yajie Qiu, Huahua Lu, Yue Zhou,
and et al. 2025. "Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case–Control Study" Vaccines 13, no. 1: 4.
https://doi.org/10.3390/vaccines13010004
APA Style
Zhu, L., Han, Y., Lu, J., Tan, J., Liao, C., Guo, C., He, Q., Qiu, Y., Lu, H., Zhou, Y., Wei, J., & Hu, D.
(2025). Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case–Control Study. Vaccines, 13(1), 4.
https://doi.org/10.3390/vaccines13010004
